^
No biomarker
Anal Carcinoma
MIXE
Sensitive
:
A2
No biomarker
Anal Carcinoma
TPF
Sensitive
:
A2
No biomarker
Anal Carcinoma
pembrolizumab
Sensitive
:
A2
No biomarker
Anal Carcinoma
nivolumab
Sensitive
:
A2
No biomarker
Anal Carcinoma
FOLFOX
Sensitive
:
A2
No biomarker
Anal Carcinoma
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Anal Carcinoma
FOLFCIS
Sensitive
:
A2
No biomarker
Anal Carcinoma
cisplatin + 5-fluorouracil
Sensitive
:
A2
No biomarker
Anal Carcinoma
mFOLFOX6
Sensitive
:
A2
No biomarker
Anal Carcinoma
capecitabine + mitomycin
Sensitive
:
A2
No biomarker
Anal Carcinoma
5-fluorouracil + mitomycin
Sensitive
:
A2
No biomarker
Anal Carcinoma
INCMGA0012
Sensitive
:
B
PD-L1 expression
Anal Carcinoma
pembrolizumab
Sensitive
:
C1
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our